Literature DB >> 24382602

Long-term survival in amyotrophic lateral sclerosis: a population-based study.

Elisabetta Pupillo1, Paolo Messina, Giancarlo Logroscino, Ettore Beghi.   

Abstract

OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify predictors of prolonged survival in a population-based cohort of newly diagnosed patients.
METHODS: An incident cohort from a population-based registry during the years 1998 through 2002 in Lombardy, Italy was followed until death or to February 28, 2013. Age, sex, date of onset of symptoms, site of onset, date of diagnosis, and El Escorial diagnostic category were collected. Survival was assessed using Kaplan-Meier curves. Cox proportional hazards function was used to identify independent prognostic predictors. Standardized mortality ratios (SMRs) were used to assess the 5-year and 10-year excess mortality of ALS patients.
RESULTS: Included were 280 men and 203 women aged 18 to 93 years. Spinal onset ALS was present in 312 cases (64.6%). Definite ALS was diagnosed in 213 cases (44.1%), probable ALS in 130 (26.9%), possible ALS in 93 (19.3%), and suspected ALS in 47 (9.7%). The cumulative time-dependent survival at 1, 5, and 10 years from diagnosis was 76.2%, 23.4%, and 11.8%, respectively. Independent predictors included younger age, the diagnosis of possible/suspected ALS, spinal onset, and symptoms having started >12 months previously at diagnosis. SMR was 9.4 at 5 years and 5.4 at 10 years. SMR at 10 years was higher until age 75 year, predominating in women, and became nonsignificant for males thereafter.
INTERPRETATION: The outcome in ALS varies with phenotype. Longer survival is predicted by younger age, spinal onset, male gender, and suspected ALS. After age 75 years, 10-year survival in men with ALS is similar to the general population.
© 2014 Child Neurology Society/American Neurological Association.

Entities:  

Mesh:

Year:  2014        PMID: 24382602     DOI: 10.1002/ana.24096

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  51 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

3.  Stratification of ALS patients' survival: a population-based study.

Authors:  Benoît Marin; Philippe Couratier; Simona Arcuti; Massimiliano Copetti; Andrea Fontana; Marie Nicol; Marie Raymondeau; Giancarlo Logroscino; Pierre Marie Preux
Journal:  J Neurol       Date:  2015-10-30       Impact factor: 4.849

4.  Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS.

Authors:  Ryan D Jacobson; Stephen A Goutman; Brian C Callaghan
Journal:  Neurology       Date:  2016-03-29       Impact factor: 9.910

5.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

Review 6.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

7.  Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis.

Authors:  Heather Jordan; Jerald Fagliano; Lindsay Rechtman; Daniel Lefkowitz; Wendy Kaye
Journal:  Neuroepidemiology       Date:  2015-03-17       Impact factor: 3.282

8.  Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis.

Authors:  Fang Fang; Tracy L Peters; John D Beard; David M Umbach; Jean Keller; Daniela Mariosa; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-11-01       Impact factor: 4.897

9.  Corticospinal tract degeneration in ALS unmasked in T1-weighted images using texture analysis.

Authors:  Abdullah Ishaque; Dennell Mah; Peter Seres; Collin Luk; Wendy Johnston; Sneha Chenji; Christian Beaulieu; Yee-Hong Yang; Sanjay Kalra
Journal:  Hum Brain Mapp       Date:  2018-10-27       Impact factor: 5.038

10.  CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis.

Authors:  Vasileios Siokas; Emmanouil Karampinis; Athina-Maria Aloizou; Alexios-Fotios A Mentis; Panagiotis Liakos; Dimitra Papadimitriou; Ioannis Liampas; Grigorios Nasios; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Neurol Sci       Date:  2020-06-26       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.